Literature DB >> 9620059

Free radical scavenging properties of apomorphine enantiomers and dopamine: possible implication in their mechanism of action in parkinsonism.

E E Sam1, N Verbeke.   

Abstract

The influence of R(-) apomorphine, S(+) apomorphine and dopamine on the oxidation kinetics of two polyunsaturated fatty acids (PUFA) (cholesteryl linoleate (CL) and Trilinolein (TL)) was investigated. The oxidation was initiated by free radicals generated through thermal decomposition of 2.2'-Azobis(2-methyl-propionitrile) (AMPN) in phosphate buffer (pH 7.4) thermostated at 50 degrees C. The hydroperoxides formed were determined by iodine titration using a diode array spectrophotometer at 290nm. Both enantiomers of apomorphine as well as dopamine exerted an inhibitory effect. Tocopherol (alpha-tocopherol) and ascorbic acid were used as controls. The former inhibited while ascorbic acid facilitated the oxidation reaction. These results are discussed in relation with the possible role of oxidative injury in parkinsonism and the usefulness of apomorphine in elevating "on-off" episodes. On this basis, the non-dopaminergic enantiomer of apomorphine (S(+)-isomer) is put foward to test the importance of its radical scavenging properties in parkinsonism which could eventually lead to a therapeutic alternative with less side effects.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9620059     DOI: 10.1007/bf02251227

Source DB:  PubMed          Journal:  J Neural Transm Park Dis Dement Sect        ISSN: 0936-3076


  9 in total

Review 1.  The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

2.  The activation of dopamine D4 receptors inhibits oxidative stress-induced nerve cell death.

Authors:  K Ishige; Q Chen; Y Sagara; D Schubert
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

3.  The neurotoxicity of glutamate, dopamine, iron and reactive oxygen species: functional interrelationships in health and disease: a review-discussion.

Authors:  J Smythies
Journal:  Neurotox Res       Date:  1999-09       Impact factor: 3.911

Review 4.  Neuroprotective strategies in Parkinson's disease : an update on progress.

Authors:  Silvia Mandel; Edna Grünblatt; Peter Riederer; Manfred Gerlach; Yona Levites; Moussa B H Youdim
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 5.  Reactive oxygen species and dopamine receptor function in essential hypertension.

Authors:  Chunyu Zeng; Van Anthony M Villar; Peiying Yu; Lin Zhou; Pedro A Jose
Journal:  Clin Exp Hypertens       Date:  2009-04       Impact factor: 1.749

Review 6.  Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice.

Authors:  Chunyu Zeng; Ines Armando; Yingjin Luo; Gilbert M Eisner; Robin A Felder; Pedro A Jose
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-12-14       Impact factor: 4.733

Review 7.  Pharmacological Insights into the Use of Apomorphine in Parkinson's Disease: Clinical Relevance.

Authors:  Manon Auffret; Sophie Drapier; Marc Vérin
Journal:  Clin Drug Investig       Date:  2018-04       Impact factor: 2.859

Review 8.  Dopamine receptors and Parkinson's disease.

Authors:  Shin Hisahara; Shun Shimohama
Journal:  Int J Med Chem       Date:  2011-06-13

9.  Memantine increases NMDA receptor level in the prefrontal cortex but fails to reverse apomorphine-induced conditioned place preference in rats.

Authors:  Ziphozethu Ndlazi; Oualid Abboussi; Musa Mabandla; Willie Daniels
Journal:  AIMS Neurosci       Date:  2018-09-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.